Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects

被引:41
作者
Schobitz, B [1 ]
Pezeshki, G [1 ]
Probst, JC [1 ]
Reul, JMHM [1 ]
Skutella, T [1 ]
Stohr, T [1 ]
Holsboer, F [1 ]
Spanagel, R [1 ]
机构
[1] MAX PLANCK INST PSYCHIAT,DEPT NEUROENDOCRINOL,D-80804 MUNICH,GERMANY
关键词
antisense targeting; oligodeoxynucleotides; sickness behavior; interleukin; 6; radiotelemetry; (rat);
D O I
10.1016/S0014-2999(97)01014-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the effects of various intracerebroventricularly administered oligodeoxynucleotides on body temperature, locomotor activity, food intake and water consumption in rats during a 24 h period with a radio-telemetric system. Both complete phosphorothioate oligodeoxynucleotides and end-inverted oligodeoxynucleotides dose-dependently elevated body temperature, suppressed food and fluid intake and inhibited nighttime activity. Apparently these effects do not depend on the nucleotide sequence because antisense and sense arginine vasopressin and oxytocin oligodeoxynucleotides, as well as a missense oligodeoxynucleotide produced comparable changes in the autonomous and behavioral parameters. in control experiments neither contaminants from the chemical synthesis nor endotoxins produced such effects, whereas native DNA from salmon sperm did. Fever and sickness-like behavior in response to missense phosphorothioate oligodeoxynucleotides were accompanied by elevated concentrations of circulating corticosterone and by a marked increase in interleukin 6 mRNA in brain and spleen, indicating that centrally administered oligodeoxynucleotides stimulate the production of pyrogenic inflammatory mediators in both central nervous system and peripheral tissues. Our results indicate that centrally administered oligodeoxynucleotides produce beside their intended sequence-specific effects also transient and sequence-independent effects due to their nucleic acid structure. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:97 / 107
页数:11
相关论文
共 36 条
[31]   ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - IS THE BULLET REALLY MAGICAL [J].
STEIN, CA ;
CHENG, YC .
SCIENCE, 1993, 261 (5124) :1004-1012
[32]   Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity [J].
Stein, CA .
TRENDS IN BIOTECHNOLOGY, 1996, 14 (05) :147-149
[33]   ANTISENSE OLIGONUCLEOTIDES - A NEW THERAPEUTIC PRINCIPLE [J].
UHLMANN, E ;
PEYMAN, A .
CHEMICAL REVIEWS, 1990, 90 (04) :543-584
[34]   ANTISENSE OLIGONUCLEOTIDE STRATEGIES IN NEUROPHARMACOLOGY [J].
WAHLESTEDT, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (02) :42-46
[35]   STABILITY, CLEARANCE, AND DISPOSITION OF INTRAVENTRICULARLY ADMINISTERED OLIGODEOXYNUCLEOTIDES - IMPLICATIONS FOR THERAPEUTIC APPLICATION WITHIN THE CENTRAL-NERVOUS-SYSTEM [J].
WHITESELL, L ;
GESELOWITZ, D ;
CHAVANY, C ;
FAHMY, B ;
WALBRIDGE, S ;
ALGER, JR ;
NECKERS, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4665-4669
[36]   MECHANISM OF OLIGONUCLEOTIDE UPTAKE BY CELLS - INVOLVEMENT OF SPECIFIC RECEPTORS [J].
YAKUBOV, LA ;
DEEVA, EA ;
ZARYTOVA, VF ;
IVANOVA, EM ;
RYTE, AS ;
YURCHENKO, LV ;
VLASSOV, VV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6454-6458